Construction, characterization, and evaluation of the vaccine potential of three genetically defined mutants of avian pathogenic Escherichia coli

Avian Diseases

Volumn 48, Issue 2, 2004, Pages 287-299

  Kariyawasam, S ^a   Wilkie, B N ^a   Gyles, C L ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Antibodies; aroA; Chickens; Efficacy; Escherichia coli; galE; Immunogenicity; Mutants; purA; Vaccine

Indexed keywords

ANIMALIA; AVES; AVIAN INFECTIOUS BRONCHITIS VIRUS; BACILLUS SUBTILIS; ESCHERICHIA COLI; GALE; GALLIFORMES; GALLUS GALLUS;

BACTERIUM ANTIBODY; ESCHERICHIA COLI VACCINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN Y; PRIMER DNA;

ANIMAL; ANIMAL DISEASE; ARTICLE; BACTERIAL GENE; BIRD DISEASE; BLOOD; CHEMISTRY; CHICKEN; ENTEROBACTER INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GENE DELETION; GENETICS; IMMUNOLOGY; METHODOLOGY; MICROBIOLOGY; MUTATION; POLYMERASE CHAIN REACTION; SAFETY; TRANSGENIC ORGANISM; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; CHICKENS; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI VACCINES; GENE DELETION; GENES, BACTERIAL; IMMUNOGLOBULINS; MUTATION; ORGANISMS, GENETICALLY MODIFIED; POLYMERASE CHAIN REACTION; POULTRY DISEASES; SAFETY; VACCINATION;

EID: 4444246207     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/7093     Document Type: Article

References (56)

1. Arp, L. H. Consequences of active or passive immunization of turkeys against Escherichia coli O78. Avian Dis. 24:808-815. 1980.
2. Avakian, A. P., and D. H. Ley. Protective immune response to Mycoplasma gallisepticum demonstrated in respiratory tract washings from M. gallisepticum-infected chickens. Avian Dis. 37:697-705. 1993.
3. Barnes, H. J., and W. B. Gross. Colibaccillosis. In: Diseases of poultry, 10th ed. B. W. Calnek, H. J. Barnes, C. W. Beard, L. R. McDougald, and Y. M. Saif, eds. Iowa State University Press, Ames, IA. pp. 131-141. 1997.
4. Barrow, P. A., K. Page, and M. A. Lovell. The virulence for gnotobiotic pigs of live attenuated vaccine strains of Salmonella enterica serovars typhimurium and enteritidis. Vaccine 19:3432-3436. 2001.
5. Cardenas, L., and J. D. Clements. Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens. Clin. Microbiol. Rev. 5:325-342. 1992.
6. Chaffer, M., B. Schwartsburd, and E. D. Heller. Vaccination of turkey poults against pathogenic Escherichia coli. Avian Pathol. 26:377-390. 1997.
7. Chatfield, S., M. Roberts, P. Londono, I. Cropley, G. Douce, and G. Dougan. The development of oral vaccines based on live attenuated Salmonella strains. FEMS Immunol. Med. Microbiol. 7:1-7. 1993.
8. Curtiss, R., III, S. M. Kelly, P. A. Gulig, and K. Nakayama. Selective delivery of antigens by recombinant bacteria. Curr. Top. Microbiol. Immunol. 146:35-49. 1989.
9. Deb, J. R., and E. G. Harry. Laboratory trials with inactivated vaccines against Escherichia coli (O78:K80) infection in fowls. Res. Vet. Sci. 20:131-138. 1976.
10. Deb, J. R., and E. G. Harry. Laboratory trials with inactivated vaccines against Escherichia coli (O2:K1) infection in fowls. Res. Vet. Sci. 24:308-313. 1978.
11. Dho-Moulin, M., and J. M. Fairbrother. Avian pathogenic Escherichia coli (APEC). Vet. Res. 30:299-316. 1999.
12. Dunstan, S. J., C. P. Simmons, and R. A. Strugnell. Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against heterologous antigen. Infect. Immun. 66:732-740. 1998.
13. Edwards, R. A., L. H. Keller, and D. M. Schifferli. Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression. Gene 207:149-157. 1998.
14. Fontaine, A., J. Arondel, and P. J. Sansonetti. Construction and evaluation of live attenuated vaccine strains of Shigella flexneri and Shigella dysenetriae 1. Res. Microbiol. 141:907-912. 1990.
15. Frommer, A., P. J. Freidlin, R. R. Bock, G. Leitner, M. Chaffer, and E. D. Heller. Experimental vaccination of young chickens with a live, non-pathogenic strain of Escherichia coli. Avian Dis. 23:425-433. 1994.
16. Fukasawa T., and Nikaido H. Galactose-sensitive mutants of Salmonella. II. Bacteriolysis induced by galactose. Biochem. Biophys. Acta 48:470-483. 1961.
17. Goren, E. Observations on experimental infection of chicks with Escherichia coli. Avian Pathol. 7:213-224. 1978.
18. Gross, W. B. Disease due to Escherichia coli in poultry. In: Escherichia coli in domestic animals and humans. C. L. Gyles, ed. CAB international, Wallingford, United Kingdom, pp. 237-259. 1994.
19. Hassan, J.O., and R. Curtiss 3rd. Efficacy of a live avirulent Salmonella typhimurium vaccine in preventing colonization and invasion of laying hens by Salmonella typhimurium and Salmonella enteritidis. Avian Dis. 41:783-791. 1997.
20. Homchampa, P., R. A. Strugnell, and B. Adler. Construction and vaccine potential of an aroA mutant of Pasteurella haemolytica. Vet. Microbiol. 42:35-44. 1994.
21. Homchampa, P., R. A. Strugnell, and B. Adler. Cross protective immunity conferred by a marker-free aroA mutant of Pasteurella multocida. Vaccine 15:203-208. 1997.
22. Hone, D., R. Morona, S. Attridge, and J. Hackett. Construction of defined galE mutants of Salmonella for use as vaccines. J. Infect. Dis. 156:167-174. 1987.
23. Kariyawasam, S., B. N. Wilkie, D. B. Hunter, and C. L. Gyles. Systemic and mucosal antibody responses to selected cell surface antigens of avian pathogenic Escherichia coli in experimentally infected chickens. Avian Dis. 46:668-678. 2002.
24. Kwaga, J. K., B. J. Allan, J. V. van den Hurk, H. Seida, and A. A. Porter. A carAB mutant of avian pathogenic Escherichia coli serogroup O2 is attenuated and effective as a live oral vaccine against colibacillosis in turkeys. Infect. Immun. 62:3766-3772. 1994.
25. Lawrence, E. C., F. Arnaud-Battandier, J. Grayson, I. R. Koski, N. J. Dooley, A. V. Muchmore, and R. M. Blaese. Ontogeny of humoral immune function in normal chickens: a comparison of immunoglobulin-secreting cells in bone marrow, spleen, lungs and intestines. Clin. Exp. Immunol. 43:450-457. 1981.
26. Lawrence, M. L., R. K. Cooper, and R. L. Thune. Attenuation, persistence, and vaccine potential of an Edwardsiella ictaluri pur A mutant. Infect. Immun. 65:4642-4651. 1997.
27. Leitner, G., D. Melamid, N. Drabkin, and E. D. Heller. An enzyme-linked immunosorbent assay for detection of antibodies against Escherichia coli: association between indirect hemagglutination test and survival. Avian Dis. 34:58-62. 1990.
28. Levine, M. M., C. Ferreccio, P. Abrego, O. S. Martin, E. Ortiz, and S. Cryz. Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine. Vaccine 17(Suppl. 2):S22-S27. 1999.
29. Levine, M. M., D. Herrington, J. R. Murphy, J. G. Morris, G. Losonsky, B. Tall, A. A. Lindberg, S. Svenson, S. Bagar, M. F. Edwards, and B. Stocker. Safety, infectivity, immunogenicity and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J. Clin. Invest. 79:888-902. 1987.
30. Lumsden, J. S., and B. N. Wilkie. Immune response of pigs to parenteral vaccination with an aromatic-dependent mutant of Salmonella typhimurium. Can. J. Vet. Res. 56:296-302. 1992.
31. Manoil, C., and J. Beckwith. TnphoA: a transposon probe for protein export signals. Proc. Natl. Acad. Sci. USA 82:8129-8133. 1985.
32. Maskell, D., K. J. Sweeney, D. O'Callaghan, C. E. Hormaeche, F. Y. Liew, and G. Dougan. Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine secretory and systemic immune systems. Microb. Pathog. 2:211-221. 1987.
33. McGhee, J. R., J. Mestecky, M. T. Dertzbaugh, J. H. Eldridge, M. Hirasawa, and H. Kiyono. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10:75-88. 1992.
34. Mekalanos, J. J. Live attenuated vaccine vectors. Int. J. Technol. Assess. Health Care 10:131-142. 1994.
35. Miller, J. H. Experiments in molecular biology. Cold Spring Harbor Laboratory Press, Plainview, NY. 1992.
36. Moral, C. H., E. F. D. Castillo, P. L. Fierro, A. V. Cortes, J. A. Castillo, A. C. Soriano, M. S. Salazar, B. R. Peralta, and G. N. Carrasco. Molecular characterization of the Aeromonas hydrophila aroA gene and potential use of an auxotrophic mutant as a live attenuated vaccine. Infect. Immun. 66:1813-1821. 1998.
37. Morona, R., J. K. Morona, A. Considine, J. A. Hackett, L. van den Bosch, L. Beyer, and S. R. Attridge. Construction of K88- and K99-expressing clones of Salmonella typhimurium G30: immunogenicity following oral administration to pigs. Vaccine 12:513-517. 1994.
38. Nakamura, K., J. K. Cook, J. A. Frazier, and M. Narita. Escherichia coli multiplication and lesions in the respiratory tract of chickens inoculated with infectious bronchitis virus and/or E. coli. Avian Dis. 36:881-890. 1992.
39. Naveh, M. W., and E. Z. Ron. 1985. Vaccination against colisepticemia in chickens. In: Proc. 34th Western Poultry Disease Conference, Davis, CA. p. 83. 1985.
40. Nivas, S. C., and B. S. Pomeroy. Attenuation of pathogenic Escherichia coli using acridine orange. Abstract. Proc. Conference of Research Workers in Animal Disease, Chicago, IL. 1978. Abstract number 81.
41. Nnalue, N. A., and B. A. Stocker. Some galE mutants of Salmonella choleraesuis retain virulence. Infect Immun. 54:635-640. 1986.
42. Nnalue, N. A., and B. A. Stocker. Test of the virulence and live-vaccine efficacy of auxotrophic and galE derivatives of Salmonella choleraesuis. Infect. Immun. 55:955-962. 1987.
43. O'Callaghan, D., D. Maskell, F. Y. Liew, C. S. Easmon, and G. Dougan. Characterization of aromatic- and purine-dependent Salmonella typhimurium: attention, persistence, and ability to induce protective immunity in BALB/c mice. Infect. Immun. 56:419-423. 1988.
44. O'Callaghan, D., D. Maskell, J. Tite, and G. Dougan. Immune responses in BALB/c mice following immunization with aromatic compound or purine-dependent Salmonella typhimurium strains. Immunology 69:184-189. 1990.
45. Peighambari, S. M., and C. L. Gyles. Construction and characterization of avian E. coli cya crp mutants. Avian Dis. 42:698-710. 1998.
46. Peighambari, S. M., D. B. Hunter, P. E. Shewen, and C. L. Gyles. Safety, immmunogenicity, and efficacy of two Escherichia coli cya crp mutants as vaccines for broilers. Avian Dis. 46:287-297. 2002.
47. Peighambari, S. M., R. L. Julian, and C. L. Gyles. Experimental Escherichia coli respiratory infection in broilers. Avian Dis. 44:759-769. 2000.
48. Roland, K., R. Curtiss 3rd, and D. Sizemore. Construction and evaluation of a delta cya delta crp Salmonella typhimurium strain expressing avian pathogenic Escherichia coli O78 LPS as a vaccine to prevent airsacculitis in chickens. Avian Dis. 43:429-441. 1999.
49. Ron, E. Z. Vaccines obtained from bacterial mutant strains. United States Patent Publication 4404186. September 13, 1983.
50. Sambrook, J., E. F. Fritsch, and T. Maniatis. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 1989.
51. Sigwart, D. F., B. A. D. Stocker, and J. D. Clements. Effect of purA mutation on efficacy of Salmonella live vaccine vectors. Infect. Immun. 57:1858-1861. 1989.
52. Stocker, B. A. D. Auxotrophic Salmonella typhi as live vaccine. Vaccine 6:141-145. 1988.
53. Trampel, D. W., and R. W. Griffth. Efficacy of aluminum hydroxide-adjuvanted Escherichia coli bacterin in turkey poults. Avian Dis. 41:263-268. 1997.
54. Vaughan, L. M., P. R. Smith, and T. J. Foster. An aromatic-dependent mutant of the fish pathogen Aeromonas salmonicida is attenuated in fish and is effective as a live vaccine against the salmonid disease furunculosis. Infect. Immun. 61:2172-2181. 1993.
55. Villarreal-Ramos, B., J. Manser, R. A. Collins, G. Dougan, S. N. Chatfield, and C. J. Howard. Immune responses in calves immunised orally or subcutaneously with a live Salmonella typhimurium aro vaccine. Vaccine 16:45-54. 1998.
56. Yoder, H. W., Jr., C. W. Beard, and B. W. Mitchell. Pathogenicity of Escherichia coli in aerosols for young chickens. Avian Dis. 33:676-683. 1989.